Evangelia Kalaitzoglou

Associate Professor

University of Kentucky

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Joseph Wolfsdorf

Attending Physician in Endocrinology; Professor of Pediatrics

Boston Children's Hospital

UNITED STATES

View details

Sze Ng

Honorary Professsor

Edge Hill University

UNITED KINGDOM

View details

Thomas J. Hawke

McMaster University

CANADA

View details

Alan Rogol

Professor, Emeritus

University of Virginia

UNITED STATES

View details

Jean-Pierre Chanoine

Clinical Professor

The University of British Columbia

CANADA

View details

Ramkumar T. Annamalai

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Evangelia Kalaitzoglou

Research Interests

Explore related searches

Contact this professor

Articles (9)

Ten-Year Experience of a Global and Freely Accessible e-Learning Website for Pediatric Endocrinology and Diabetes

Bringing the Pediatric Endocrine Spanish Speaking Community Together: First Virtual Pediatric Endocrine Meeting in Low- and Middle-Income Countries in Central and South America

Biomechanical Stimulation of Muscle Constructs Influences Phenotype of Bone Constructs by Modulating Myokine Secretion

Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes

Multilingual Global E-Learning Pediatric Endocrinology and Diabetes Curriculum for Front Line Health Care Providers in Resource-Limited Countries: Development Study

Muscle and serum myostatin expression in type 1 diabetes.

Postnatal loss of the insulin receptor in osteoprogenitor cells does not impart a metabolic phenotype.

Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits

Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization

Collaborators (6)

Joseph Wolfsdorf

Sze Ng

Thomas J. Hawke

Alan Rogol

Jean-Pierre Chanoine

Ramkumar T. Annamalai

Make your next move.